Dr. Mohammed G. Elhassan, MD

Dr. Elhassan practices at Saint Agnes Medical Center in Fresno, California, part of Trinity Health.

Dr. Elhassan's NPI, 1437425550, was assigned on March 23, 2012. Dr. Elhassan graduated from University of Khartoum Faculty of Medicine in 2003. Dr. Elhassan holds California license A125562.

Dr. Elhassan's primary practice is Saint Agnes Medical Center, at 1303 E Herndon Ave, Fresno, CA 93720 in Fresno County. The practice phone is (559) 450-3000.

Dr. Elhassan's primary practice is Saint Agnes Medical Center in Fresno, California, part of Trinity Health. Dr. Elhassan is also affiliated with Community Regional Medical Center. The medical group on file is Saint Agnes Care. Dmand AI also links Dr. Elhassan to 1 more medical group, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Elhassan practices, 2 sites in all. Vendor and product names are available with a free account.

Hospitalist is Dr. Elhassan's primary specialty in the NPI Registry, under taxonomy code 208M00000X. Dr. Elhassan is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Elhassan's licenses on file in 2 states: California and New Jersey.

Dmand AI lists acute diabetes, acute respiratory failure, cardiac arrhythmia, cellulitis, chest pain, collapsed lung, congestive heart failure and electrolyte disorders among the conditions Dr. Elhassan treats.

CMS data shows 1,038 Medicare services from Dr. Elhassan across 6 procedure codes in 2024, for 318 Medicare patients. Medicare paid $83,862 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 318 Medicare patients who saw Dr. Elhassan in 2024. The largest group is 75 to 84, with 103 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 49% are also on Medicaid. Their average risk score is 2.71, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Elhassan's median patient age at 69, with 52% women.

In 2024, Dr. Elhassan wrote 45 Medicare Part D claims for 23 patients. 96% of them were for generic drugs. CMS names the drug for 14 of them, across 1 drug with 11 or more claims each, at $62 in total drug cost. In 2022, CMS named 68 claims across 5 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 86 out of 100 for Dr. Elhassan for performance year 2024, reported as part of a group. Dr. Elhassan accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 15 papers to Dr. Elhassan, published from 2018 to 2025. 2022 was the busiest year, with 3. Dr. Elhassan has published most often in Cureus. Dr. Elhassan's most frequent co-authors are Pal Satyajit Singh Athwal, MD, Harjot Kaur Bath, MD and Uday R. Chauhan, MD, PA.

CMS Open Payments shows 10 general payments to Dr. Elhassan from 5 drug and device companies from 2018 to 2024. Food and beverage make up the largest share, 100% of the total. CeQur Corporation paid the most, $105.

Dr. Elhassan graduated from University of Khartoum Faculty of Medicine in 2003.

Dr. Elhassan is in network with 12 carriers, including Aetna, United Healthcare and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 8. Check the plan with the practice before a visit.